(a) Specifications.
The drug is in a powder form containing acetazolamide sodium, USP equivalent to 25 percent acetazolamide activity.
(b) Sponsor.
See No. 053501 in § 510.600(c) of this chapter.
(c) Conditions of use.
(1)
It is used in dogs as an aid in the treatment of mild congestive heart failure and for rapid reduction of intraocular pressure. 1
Code of Federal Regulations
Footnote(s):
1 These conditions are NAS/NRC reviewed and deemed effective. Applications for these uses need not include effectiveness data as specified by § 514.111 of this chapter, but may require bioequivalency and safety information.
(2)
It is administered orally at a dosage level of 5 to 15 milligrams per pound of body weight daily. 1
(3)
For use only by or on the order of a licensed veterinarian. 1
Code of Federal Regulations
[40 FR 13838, Mar. 27, 1975, as amended at 67 FR 78355, Dec. 24, 2002]